What You Should Know:
– No Barrier, the leader in AI-powered medical translation redefining language access in healthcare, today announced an oversubscribed $2.7 million Seed Round led by A-Squared Ventures, Esplanade Ventures, Rock Health Capital and Fusion.
– No Barrier’s AI-powered real time language interpretation technology integrates into existing clinician workflows, improving providers’ and health systems’ limited-English-proficiency (LEP) services to the highest quality with zero-wait access.
AI-Powered Interpretation Designed for Healthcare
No Barrier is an AI-driven clinical interpretation platform built specifically to eliminate language barriers across the entire care continuum. The HIPAA- and SOC 2–compliant system provides fast, private, and clinically validated interpretation in more than 40 languages, offering healthcare organizations an integrated, end-to-end alternative to traditional third-party interpreter services.
Unlike general-purpose translation tools, No Barrier’s technology is engineered for healthcare: it embeds directly into clinical workflows, supports EHR integration, and maintains enterprise-grade security. With new funding, the company is accelerating deployment across all points of care—from front-desk intake to bedside discussions and treatment-plan delivery—ensuring uninterrupted language access throughout a patient’s journey.
The need is substantial. More than 25.7 million Americans have limited English proficiency, leading to delayed diagnoses, preventable complications, and higher readmission rates. No Barrier addresses this challenge with instant, compliant interpretation that reduces wait times entirely and helps facilities cut interpretation costs by up to 70%. Providers benefit from reliable, clinical-grade accuracy, while patients receive timely care free from communication delays.
Today, No Barrier is used in more than 100 healthcare sites across 12 states, supporting a wide range of clinical areas including mental health, reproductive care, pediatrics, and others. By removing external interpreters from sensitive encounters, the platform restores privacy, preserves patient dignity, and strengthens trust between patients and clinicians.
Led by a founding team with a track record of success in Voice AI and supported by experienced healthcare leaders, the company continues to advance its mission of making immediate, accurate communication available to every patient. CEO Eyal Heldenberg underscored this commitment, noting that the platform allows health systems to standardize communication quality and compliance across diverse provider networks.
